Comparing the current results to its competitors, Stryker reported Revenue increase in the 2 quarter 2026 by 9.42 % year on year. The sales growth was above Stryker's competitors' average revenue growth of 7.47 %, achieved in the same quarter.
Stryker's Comment on Competition and Industry Peers
The company operates in multiple medical device sectors, competing globally with several key industry players. In the Instruments segment, its main competitors include Zimmer Biomet Holdings, Inc., Medtronic plc, Johnson & Johnson MedTech, and ConMed Linvatec, Inc. Within Endoscopy, it faces competition from Karl Storz GmbH & Co., Olympus Optical Co. Ltd., Smith & Nephew plc, ConMed Linvatec, Arthrex, Inc., and STERIS plc. In the Medical Products category, primary competitors are Baxter International Inc., Zoll Medical Corporation, Medline Industries, and Ferno-Washington, Inc. For Vascular and Neuro Cranial products, competitors include Medtronic, Johnson & Johnson MedTech, Terumo Corporation, and Penumbra, Inc. In the areas of joint replacement, trauma and extremities products, and robotics, the company competes with Zimmer, Johnson & Johnson MedTech, and Smith & Nephew. The company identifies innovation, quality, service, and patent protection as key factors in its competitive positioning.
With revenue growth of 9.42 % within Overall company, Stryker Corp achieved improvement in market share, within Overall company to approximately 3.67 %. << More on SYK Market Share.
*Market share is calculated based on total revenue.
October 1, 2024
In the ever-evolving landscape of the healthcare industry, Stryker Corporation continues to establish itself as a leader, showing remarkable resilience and commitment to financial accountability. Based in Portage, Michigan, Stryker (NYSE:SYK) is set to unveil its third quarter financial results for fiscal year 2024 on October 29, 2024. This announcement aligns perfectly with the company’s ongoing strategy of providing timely and transparent financial disclosures, which is crucial for investors and stakeholders alike.The financial results for the quarter ending September 30 are eagerly anticipated by the market, with the press release scheduled for distribution at approximately 4:05 PM ET on the aforementio...
August 19, 2024
Stryker Corporation, a global leader in medical technology, has revealed plans to participate in the 2024 Wells Fargo Healthcare Conference, scheduled for September 5 at the prestigious Encore Boston Harbor. This participation underscores Stryker s commitment to engaging with stakeholders and providing insights into their ongoing strategies and performance metrics. As Stryker gears up for this notable event, it’s crucial to spotlight their recent financial performance. In the second quarter of 2024, Stryker reported a robust revenue increase of 8.53% year over year, significantly outpacing their competitors average revenue growth of just 1.08% for the same quarter. This impressive growth rate showcases th...
Vicarious Surgical Inc utilizes a business model that combines robotics and virtual reality to revolutionize surgical procedures. Their technology allows surgeons to perform minimally invasive surgeries with precision and control using robotic arms guided by a virtual reality interface. By offering an innovative solution to traditional surgical methods, Vicarious Surgical aims to enhance patient outcomes while minimizing the invasiveness and risks associated with traditional procedures.
Boston Scientific Corporations business model centers on creating innovative medical devices for diverse specialties, aimed at addressing unmet medical needs and enhancing patient outcomes. The company sells its products to healthcare professionals and hospitals globally, supported by robust sales and distribution networks. It prioritizes research and development to continually introduce new technologies and solutions.
Edwards Lifesciences Corporations business model focuses on the development and commercialization of advanced medical technologies that enhance the diagnosis and treatment of heart disease, emphasizing innovative heart valves and critical care monitoring solutions. The company serves a diverse customer base, including hospitals and direct-to-patient markets, with a strong commitment to improving patient outcomes and quality of life.
Sources:
Stryker Corp’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Stryker Corp versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
